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Abstract According to World Health Organization (WHO),
about 1 out of 10 hospitalized patients suffers an adverse event,
in developed countries, being an adverse event an injury related
to medical management, in contrast to complications of disease.
These events cause both unnecessary suffering and huge cost to
health systems. This issue is so important that WHO has defined
it as a global health problem and in 2004 launched the World
Alliance for Patient Safety, with the aim to coordinate, dissemi-
nate and accelerate improvements in Patient Safety. Office Hys-
teroscopy (OH), as an independent technique of the hospital
circuit, has the ideal conditions to be qualified as the gold stan-
dard technique for the surgical treatment of intracavitary uterine
pathology. It does not require the use of an operating room,
hospital admission and general or locoregional anaesthesia.
The appropriate surgical techniques, allied to pain control, allow
OH to resolve much more than 90 % of the surgical needs of the
intracavitary uterine pathology, thus being an important contri-
bution for Patient Safety.
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Background
The problem of adverse events in health care is known since
1950s. The subject remained largely neglected until early
1990s, when the results of the HarvardMedical Practice Study
in 1991 [1, 2] warned of the dimension of the problem in a
new economic and social context. Subsequent research in
Australia [3], the United Kingdom of Great Britain and North-
ern Ireland [4] and the USA and in particular the 1999 publi-
cation To err is human: building a safer health system by the
Institute of Medicine [5] provided further data and brought the
subject to the top of the policy agenda and the forefront of
public debate worldwide. Today, this is a well-known problem
and the World Health Organization launched in 2004 the
World Alliance for Patient Safety. Some facts mentioned in
this Forward Programme in 2004 (http://www.who.int/
patientsafety/worldalliance/en/) illustrate the problem:
Estimates show that in developed countries as many
as 1 in 10 patients is harmed while receiving hospital
care. The harm can be caused by a range of errors or
adverse events (http://www.who.int/patientsafety/
worldalliance/en/).
Hospital infections affect 14 out of every 100 patients ad-
mitted (http://www.who.int/patientsafety/worldalliance/en/).
Surgical care is associated with a considerable risk of com-
plications. Surgical care errors contribute to a significant bur-
den of disease despite the fact that 50 % of complications
associated with surgical care are avoidable (http://www.who.
int/patientsafety/worldalliance/en/).
Safety studies show that additional hospitalization, litiga-
tion costs, infections acquired in hospitals, disability, lost pro-
ductivity and medical expenses cost some countries as much
as US$ 19 billion annually. The economic benefits of improv-
ing Patient Safety are therefore compelling (http://www.who.
int/patientsafety/worldalliance/en/).
Industries with a perceived higher risk such as the aviation
and nuclear industries have a much better safety record than
health care. There is 1 in 1,000,000 chances of a traveler being
harmed while in an aircraft. In comparison, there is 1 in 300
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chances of a patient being harmed during health care (http://
www.who.int/patientsafety/worldalliance/en/).
There is now growing recognition that Patient Safety and
Quality are a critical dimension of universal health coverage.
A research carried out in three public hospitals in great
Lisbon area in 2011 based on a sample of 1669 hospitalized
patients and a total of 47,783 hospital admissions showed an
Adverse Event’s (AE) incidence of 11.1%, and the most crit-
ical places were the room or nursery (49.7 % of the AE) and
the operating room (23.9 % of the AE) [6].
Regarding office practice in gynaecological and obstetrics
procedures, a task force was convened in 2008 by the Amer-
ican College of Obstetricians and Gynaecologists (ACOG).
The primary impetus to creating this task force was the steady
migration of surgical procedures to the office that had solely
been performed in the hospital or ambulatory surgical center,
and this transition began with hysteroscopy in the 1980s [7].
In 2004, Bettochi et al. [8] reported on 4863 operative
hysteroscopic procedures performed using a 5.0-mm diameter
operative hysteroscope and 5F instruments. The procedures
included the removal of cervical and endometrial polyps along
with adhesiolysis and repair of Banatomic impediments^, by
using a vaginoscopic technique Bwithout analgesics or
anaesthesia^, and noted that patients reported little discomfort,
although those undergoing removal of endometrial polyps
were more likely to experience Bmoderate^ discomfort [9].
So, why would Office Hysteroscopy be such an important
contribution for the Patient Safety?
Because, firstly, it is a procedure independent from the
hospital circuit, thus avoiding risk of adverse events associat-
ed to hospitalization. Secondly, OH has clear advantages be-
fore operating room (OR) hysteroscopy, eliminating compli-
cations of general or locoregional anaesthesia, being limited
only by its surgical ability and pain control.
Methods
All our OH have been performed by see and treat hysterosco-
py and by vaginoscopic approach at the Department of Gy-
naecology and Obstetrics of the Hospital das Forças Armadas
in Lisbon.
Preceding all hysteroscopies, patients were evaluated re-
garding need to treat vaginal pathological discharge, need
for local or systemic hormonal treatment and use of
misoprostol.
All patients were submitted to pelvic transvaginal ultra-
sound prior to procedure.
In the day of the hysteroscopy, recta l 10 mg
butylscopolamine with 800 mg paracetamol and oral 5 mg
diazepam were administered to all patients before the
procedure.
Hysteroscopies were performed using rigid 5Fr Bettocchi®
hysteroscopes with 30° optic. The distension medium used
was saline solution at 37 °C, and the electrodes were Twizzle
type bipolar from Versapoint®, apart from mechanical instru-
ments. Hysteroscopic anaesthesia (HA), a method of local
anaesthesia using an endoscopic needle, was given when re-
quested by the patients, using a Williams Cystoscopic Injec-
tion Needle, 22 ga (length 35 cm, point 8 mm) [10]. This
method was first described in 2009 by Skensved [11] and
allows administration of focal local uterosacral, endocervical
or even intracavitary anaesthesia (1 % lidocaine), under hys-
teroscopic visualization, with no need to interrupt the proce-
dure or use of speculum [10]. When HAwas decided, accord-
ing to specific locations, 1 % lidocaine was injected through
the hysteroscope: around 1 cm3 per location in the
endocervical region, near the internal os or intracavitarily, or
2 cm3 at both uterosacral ligaments, if necessary, to a limit of
10 cm3 maximum per hysteroscopy.
Procedures were performed by both experienced
hysteroscopists and trainees, recorded on DVD, photographed
and registered in our database during the global period of
February 2012 to April 2014, accordingly to Table 1.
We questioned the patients about pain felt during proce-
dures, by an anonymous survey using a 0–10 pain scale, in
which 0 corresponded to no pain and 10 to maximum pain
experienced before.
We rely on three retrospective studies conducted in our
department: one between April 2011 and April 2014 (330
procedures) that assessed the number of patients sent to the
OR, another between May 2010 and March 2012 (207 proce-
dures) that evaluated effectiveness of HA and another between
January 2010 and December 2012 (230 procedures) that eval-
uated the dimensions of the excised masses in OH.
Findings
In our study that assessed the efficacy of Office Hysteroscopy,
45% ofwomenwere in premenopause and 55% of themwere
in postmenopause. Regarding parity, 28%were nulliparous or
never had a vaginal delivery and 72% had at least one vaginal
delivery. Procedures were performed by both experienced
hysteroscopists and trainees and were chirurgical in 239 cases,
Table 1 Characterization of hysteroscopies according to the degree of
professional experience
Office Hysteroscopy Hysteroscopic time (average—min) Sent to OR
Diagnostic 24.7 % Total Experts Trainees 5.7 %
Operative 75.3 % 24.6 21.7 24.6
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mainly polypectomies (191), followed by myomectomies
(29), tubal ligation by Essure® (24) and adhesion lysis (3).
We performed 87 diagnostic hysteroscopies.
Of the total 330 hysteroscopies, only 23 % had HA. Fifty-
six per cent of those patients who received HA referred good
tolerance to the procedure, 37 % had a level of pain between 7
and 10, on a 0–10 scale, and in 7 %, the procedure was not
concluded.
In this study, we concluded that OH was successful in about
92–95 % of the cases [9], without resorting to the OR. The pro-
cedures were generally well tolerated. In 330 cases by Bsee and
treat^OH, 97.85% [12] of the cases were successfully concluded
and only 2.15% [9] of the patients were sent to the OR.
In the study that evaluated effectiveness of HA, patients
had ages between 14 and 91 years (average 54); 95 of them
were in premenopause and 112 in post menopause [12]. Re-
garding parity, 49 were nulliparous or never had a vaginal
delivery and 158 had at least one vaginal delivery [12]. Pro-
cedures were performed by both experienced hysteroscopists
and trainees and were chirurgical in 148 cases, mainly
polypectomies (119), followed by myomectomies (15), tubal
ligation by Essure® (15) and adhesion lysis (1) [12]. Only 59
hysteroscopies were diagnostic [12].
We concluded the procedure in 85 % [12] of patients, with
mild to moderate pain referred. When HAwas administered,
in 54 cases [12], the intensity of pain was clearly inferior,
allowing procedure closure in 93 % [12] of these patients,
which otherwise would be sent to OR. Therefore, it proved
to be effective and more comfortable to the patient, since there
is no need for the use of speculum or procedure interruption.
In the study that evaluated the dimensions of the excised
masses, patients had ages between 14 and 91 years (average
57), 40 % of them were in premenopause and 60 % in post-
menopause [13]. Regarding parity, 26 % were nulliparous or
never had a vaginal delivery and 74% had at least one vaginal
delivery [13]. Procedures were performed by both experi-
enced hysteroscopists and trainees and were all chirurgical,
mainly polypectomy, followed by myomectomy [13]. The
biggest polyp removed was 72 mm long, and the biggest my-
oma was 58 mm long [13].
Population was divided in three groups, considering re-
moved masses size: group 1, masses measuring less than
2 cm (158 procedures); group 2, masses of 2 cm or larger
and inferior to 5 cm (55 procedures); and group 3, masses of
5 cm or larger (17 procedures) [13].
Most patients reported only slight pain or discomfort dur-
ing the procedure [13]. The pain level was ≤5 in 73.1 % [13]
of patients. Only 17 % [13] requested HA and 10 % [13]
expressed willingness for general anaesthesia, but only
7.4 % were sent to OR, 52 % of those belonging to group 1
[13].On univariate analysis, size or number of masses was not
related to the intensity of pain felt, or with the willingness for
general anaesthesia [13].
We concluded that the probability of more than one proce-
dure per mass was higher with larger masses, being 20 % of
patients submitted to more than one hysteroscopy. Masses
smaller than 2 cm did not need more than two procedures,
and one patient with a mass larger than 5 cm needed four
procedures [13].
In this study, we were able to excise 17 masses larger than
5 cm [13], thus concluding that the removal of masses larger
than 5 cm is practicable in OH.
In 92.6 % [13] of patients, we were able to avoid the risks
associated with general or locoregional anaesthesia as well as
the adverse effects and costs associated to hospitalization.
Conclusions
Office Hysteroscopy is a safe and effective technique, inde-
pendent of the hospital circuit, not requiring the use of OR,
hospital admission and general or locoregional anaesthesia,
being therefore an important contribution for Patient Safety
and Health Quality in gynaecology. Actually, OH has the ideal
conditions to be qualified as the gold standard technique for
the surgical treatment of intracavitary uterine pathology.
HA guaranties more comfort to the patient because it is
speculum free and needs no hysteroscopy interruption. The
use of HA, only when solicited, reduces costs and risks, ef-
fectively reducing pain, which allows closure of the proce-
dure. Its focal characteristic also enhance HO capability, es-
pecially in myomectomies, where it can be administrated in-
tracavitarily, preventing posterior OR procedure.
The removal of masses larger than 5 cm is controversial,
but is possible, although it might imply more procedures per
mass. That factor does not limit OH capability since the inten-
sity of pain felt, or the willingness for general anaesthesia, is
not directly related to the number of procedures.
It is therefore feasible to remove these masses, although it
is technically challenging for the experienced hysteroscopist,
because it implies balancing the tolerability of the patient and
the control of the uterine cavity.
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